BRAINSTORM CELL THERAPEUTICS INC. Operating Expenses
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Operating Expenses of $2.21 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2015-05-14
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for the quarter ending 2015-03-31 was $2.21M, a 113.87% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for the quarter ending 2014-12-31 was $2.67M, a 90.44% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for the quarter ending 2014-09-30 was $2.43M, a 125.65% increase year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for the quarter ending 2014-06-30 was $1.29M, a 12.86% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for fiscal 2014 was $7.42M, a 47.15% increase from fiscal 2013.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for fiscal 2013 was $5.04M, a 43.35% increase from fiscal 2012.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for fiscal 2012 was $3.52M, a 9.66% decline from fiscal 2011.
- BRAINSTORM CELL THERAPEUTICS INC. operating expenses for fiscal 2011 was $3.89M, a 50.41% increase from fiscal 2010.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 129 month | Operating Expenses 132 month | Operating Expenses 135 month | Operating Expenses 138 month | Operating Expenses 141 month | Operating Expenses 144 month | Operating Expenses 147 month | Operating Expenses 150 month | Operating Expenses 153 month | Operating Expenses 156 month | Operating Expenses 159 month | Operating Expenses 162 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $2.21M 10-Q · filed 2015-05-14 | $4.87M derived: sum of 2 quarters · filed 2015-05-14 | $7.30M derived: sum of 3 quarters · filed 2015-05-14 | $8.60M derived: sum of 4 quarters · filed 2015-05-14 | |||||||||||||||
| 2014-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $5.10M derived: sum of 2 quarters · filed 2015-03-26 | $6.39M derived: sum of 3 quarters · filed 2015-03-26 | $7.42M 10-K · filed 2015-03-26 | |||||||||||||||
| 2014-09-30 | $2.43M 10-Q · filed 2014-11-13 | $3.72M derived: sum of 2 quarters · filed 2014-11-13 | $4.75M 10-Q · filed 2014-11-13 | $6.15M derived: sum of 4 quarters · filed 2015-05-14 | |||||||||||||||
| 2014-06-30 | $1.29M 10-Q · filed 2014-08-12 | $2.33M 10-Q · filed 2014-08-12 | $3.73M derived: sum of 3 quarters · filed 2015-05-14 | $4.80M derived: sum of 4 quarters · filed 2015-05-14 | |||||||||||||||
| 2014-03-31 | $1.03M 10-Q · filed 2015-05-14 | $2.43M derived: sum of 2 quarters · filed 2015-05-14 | $3.51M derived: sum of 3 quarters · filed 2015-05-14 | $4.99M derived: sum of 4 quarters · filed 2015-05-14 | $50.99M 10-Q · filed 2014-05-13 | ||||||||||||||
| 2013-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $2.48M derived: sum of 2 quarters · filed 2015-03-26 | $3.96M derived: sum of 3 quarters · filed 2015-03-26 | $5.04M 10-K · filed 2015-03-26 | $5.02M 10-K · filed 2014-03-27 | $49.96M 10-K · filed 2014-03-27 | |||||||||||||
| 2013-09-30 | $1.08M 10-Q · filed 2014-11-13 | $2.56M derived: sum of 2 quarters · filed 2014-11-13 | $3.64M 10-Q · filed 2014-11-13 | $4.28M derived: sum of 4 quarters · filed 2014-11-13 | $48.58M 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | $1.49M 10-Q · filed 2014-08-12 | $2.57M 10-Q · filed 2014-08-12 | $3.20M derived: sum of 3 quarters · filed 2014-08-12 | $4.37M derived: sum of 4 quarters · filed 2014-08-12 | $47.51M 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | $1.08M 10-Q · filed 2014-05-13 | $1.72M derived: sum of 2 quarters · filed 2014-05-13 | $2.89M derived: sum of 3 quarters · filed 2014-05-13 | $3.72M derived: sum of 4 quarters · filed 2014-05-13 | $46.02M 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.81M derived: sum of 2 quarters · filed 2014-03-27 | $2.64M derived: sum of 3 quarters · filed 2014-03-27 | $3.52M 10-K · filed 2014-03-27 | $44.94M 10-K · filed 2013-03-14 | ||||||||||||||
| 2012-09-30 | $1.17M 10-Q · filed 2013-11-14 | $2.00M derived: sum of 2 quarters · filed 2013-11-14 | $2.88M 10-Q · filed 2013-11-14 | $4.29M derived: sum of 4 quarters · filed 2013-11-14 | $44.31M 10-Q · filed 2012-11-13 | ||||||||||||||
| 2012-06-30 | $833.00K 10-Q · filed 2013-08-14 | $1.71M 10-Q · filed 2013-08-14 | $3.12M derived: sum of 3 quarters · filed 2013-08-14 | $3.85M derived: sum of 4 quarters · filed 2013-08-14 | $43.13M 10-Q/A · filed 2012-08-29 | ||||||||||||||
| 2012-03-31 | $879.00K 10-Q · filed 2013-05-09 | $2.28M derived: sum of 2 quarters · filed 2013-05-09 | $3.02M derived: sum of 3 quarters · filed 2013-05-09 | $4.44M derived: sum of 4 quarters · filed 2013-05-09 | $42.30M 10-Q · filed 2012-05-11 | ||||||||||||||
| 2011-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $2.14M derived: sum of 2 quarters · filed 2013-03-14 | $3.56M derived: sum of 3 quarters · filed 2013-03-14 | $3.89M 10-K · filed 2013-03-14 | $41.42M 10-K · filed 2012-03-15 | ||||||||||||||
| 2011-09-30 | $740.00K 10-Q · filed 2012-11-13 | $2.15M derived: sum of 2 quarters · filed 2012-11-13 | $2.49M 10-Q · filed 2012-11-13 | $3.41M derived: sum of 4 quarters · filed 2012-11-13 | $40.02M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $1.42M 10-Q/A · filed 2012-08-29 | -$1.42M 10-Q/A · filed 2011-09-07 | $1.94M 10-Q/A · filed 2012-08-29 | -$1.94M 10-Q/A · filed 2011-09-07 | $2.67M derived: sum of 3 quarters · filed 2012-08-29 | $3.31M derived: sum of 4 quarters · filed 2012-08-29 | -$39.47M 10-Q/A · filed 2011-09-07 | ||||||||||||
| 2011-03-31 | $528.00K 10-Q · filed 2012-05-11 | $1.26M derived: sum of 2 quarters · filed 2012-05-11 | $1.89M derived: sum of 3 quarters · filed 2012-05-11 | $1.28M derived: sum of 4 quarters · filed 2012-05-11 | |||||||||||||||
| 2010-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $1.36M derived: sum of 2 quarters · filed 2012-03-15 | $748.00K derived: sum of 3 quarters · filed 2012-03-15 | $2.59M 10-K · filed 2012-03-15 | |||||||||||||||
| 2010-09-30 | $635.00K 10-Q · filed 2011-11-14 | $19.00K derived: sum of 2 quarters · filed 2011-11-14 | $1.86M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | -$616.00K 10-Q/A · filed 2011-09-07 | -$1.23M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |